Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On July 22, 2025, Imunon, Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) to register an additional $4,500,000 of
. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Thompson Hine LLP . 23.1 Consent of Thompson Hine LLP (included in Exhi